President
CurrentPiomic Medical, headquartered in Zurich, Switzerland with a U.S. subsidiary in Chicago, is a medtech startup and pioneer in the development of innovative medical devices for the treatment of chronic and acute wounds.In late 2022 the U.S. Food and Drug Administration (FDA) fully approved Piomic’s Investigational Device Exemption (IDE) application for MAVERICKS, the COMS® One therapy system pivotal trial in patients with refractory diabetic foot ulcers.The COMS® One therapy system was awarded CE Mark Approval in May 2020 and is commercially available in select global markets during an initial soft launch phase.